Search Results for: embryonic stem cells

Autologous or Allogeneic: a stem cell question (guest post from Jeanne Loring)

stem-cells-and-development-parkinsons-disease

By Jeanne Loring What can you do with cells that live forever and can make every cell type in the body?  The answer is: remarkable things, as new reports of clinical trials using cell types derived from pluripotent stem cells indicate. Pluripotent stem cells are either derived from embryos donated from IVF procedures (human embryonic […]

Autologous or Allogeneic: a stem cell question (guest post from Jeanne Loring) Read More »

Papers on artificial embryos and muscle stem cells

Beccari-et-al-Nature-2018-pub-Fig-1a

If you are sick of the general news lately, I recommend turning to the wonder of cool science like the thought-provoking data in the duo of new stem cell pubs discussed below including on artificial embryos. Synthetic embryos A team led by Alfonso Martinez-Arias reports new findings in their Nature letter in the growing area

Papers on artificial embryos and muscle stem cells Read More »

Stem cell news bites: Astellas trial, cystic fibrosis claim, a few cool papers

Matoba-et-al-Figure-2c-2018

Stem cell news is always burbling up, sometimes right there in front of us on the web and other times via networks of people. Astellas news. Some may remember there used to be this pioneering stem cell biotech called ACT, which then became Ocata, and finally was acquired by the big company Astellas. One of

Stem cell news bites: Astellas trial, cystic fibrosis claim, a few cool papers Read More »

Possible safety concerns from new stem cell, RPE vision loss study report

Figure-1-Mehat-et-al.-AAO-Journal-2018-810x1024-1

With stem cells for vision loss, first we want to be sure a treatment won’t make things worse. Several teams around the globe are rigorously studying stem cell-based approaches to vision loss via regulatory-compliant studies including for macular degeneration with some results cautiously upbeat on safety from early phase analyses, but data from a new study on

Possible safety concerns from new stem cell, RPE vision loss study report Read More »